Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the license allows.
/PRNewswire/ Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that develops, manufactures and markets.
/PRNewswire/ Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that develops, manufactures and markets.